期刊文献+

子宫颈石蜡包埋样本检测HPV E6/E7mRNA用于子宫颈癌筛查的价值 被引量:3

The application value of HPV E6/E7 mRNA detection in paraffin-embedded samples for cervical cancer screening
原文传递
导出
摘要 目的 探讨检测石蜡包埋样本HPV E6/E7 mRNA在子宫颈癌筛查及预后判断中的应用价值.方法 应用支链DNA技术对石蜡包埋样本行HPV E6/E7 mRNA定量检测,以病理学诊断结果为标准分组并对拷贝值进行分析.比较各组间HPV E6/E7 mRNA阳性率及拷贝均数.结果 子宫颈癌组的HPVE 6/E7 mRNA阳性率高于子宫颈上皮内瘤变(CIN)1、CIN2、CIN3组、慢性子宫颈炎组[分别为94.29%(66/70)、30.30%(20/66)、50.00%(19/38)、59.46%(44/74)、5.66 %(3/50),均P< 0.004 5],CIN组的阳性率均高于慢性子宫颈炎组(P<0.004 5).CIN2组和CIN3组的阳性率均高于CIN1组(P<0.0045),CIN2组和CIN3组间的阳性率差异无统计学意义(P>0.004 5).子宫颈癌组的拷贝值高于慢性子宫颈炎组、CIN1、CIN2、CIN3组(分别为16 508.730±8 741.402、929.337±460.880、3 239.681±1 447.399、5 286.224±2 933.445、4.941±2.263,均P<0.05),CIN组的拷贝值均高于慢性子宫颈炎组(P<0.05),CIN3组的拷贝数值高于CIN1组(P<0.05),CIN1组和CIN2组、CIN2组和CIN3组间的拷贝值差异均无统计学意义(P>0.05).结论 HPV E6/E7 mRNA阳性率和拷贝值的变化趋势与子宫颈病变的程度有关.子宫颈石蜡包埋组织检测HPV E6/E7 mRNA在预见疾病风险上有较高的临床应用价值,可作为子宫颈癌筛查和指导随访的有效措施. Objective To explore the application value of detecting HPV E6/E7 mRNA in cervical cancer screening and prognosis.Methods bDNA technology was used to detect the HPV E6/E7 mRNA levels in 301 cases of paraffin-embedded cervical samples that were grouped based on pathological diagnosis.Statistic differece between multiple groups were assessed by chi-square segmentation method.Results The positive detection rate of HPV E6/E7 mRNA is higher in cervical cancer group than that in CIN1-3 groups and cervicitis group,which were 94.29 % (66/70),30.30 % (20/66),50.00 % (19/38),59.46 % (44/74),5.66 % (3/50),respectively (all P 〈 0.004 5).The HPV E6/E7-positive rates in all three CIN groups were higher than that in cervicitis group (P 〈 0.004 5).The positive rates in CIN2 and CIN3 group were higher than that in CIN1 group (P 〈 0.004 5).HPV E6/E7 mRNA levels in cervical cancer group were higher than those in CIN groups and cervicitis group (16 508.730±8 741.402,929:337±460.880,3 239.681±1 447.399,5 286.224±2 933.445,4.941±2.263,respectively,all P 〈 0.05).CIN groups had higher copy numbers of HPV E6/E7 mRNA than cervicitis group (P 〈 0.05).More copies of HPV E6/E7 mRNA were detected in CIN3 group than those in CIN1 group (P 〈 0.05).Conclusions The positive rate and expression levels of HPV E6/ E7 mRNA was related to the severity of cervical diseases.HPV E6/E7 mRNA detection in paraffin-embedded samples have a high clinical application value in predicting the risk of cervical cancer.It' s an effective measure for cervical cancer screening and follow-up.
出处 《肿瘤研究与临床》 CAS 2014年第4期243-245,共3页 Cancer Research and Clinic
关键词 人乳头瘤病毒 宫颈肿瘤 宫颈上皮内瘤样病变 RNA 信使 石蜡包埋 Human papillomavirus Uterine cervical neoplasms Cervical intraepithelial neoplasia RNA,messenger Paraffin embedding
  • 相关文献

参考文献10

  • 1Vince A,Lepej SZ.Diagnostic methods and techniques in cervical cancer prevention PartⅡ:Molecular diagnostics of HPV infection[J].Med Glas,2010,7:18-25.
  • 2Cattani P,Siddu A,D'Onghia S,et al.2009.RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus[J].Clin Microbiol,2009,47:2136-2141.
  • 3王华,陈亚宝,叶丽华,叶军,袁冬兰.应用支链DNA技术检测人乳头瘤病毒E6/E7mRNA在宫颈疾病筛查中的价值[J].中华临床医师杂志(电子版),2011,5(15):4362-4366. 被引量:29
  • 4张凤芹,张清泉,侯素平,邱雷,冀雪霞.应用支链DNA技术检测宫颈高危人乳头瘤病毒E6/E7 mRNA[J].国际检验医学杂志,2013,34(6):705-706. 被引量:5
  • 5Sorbye SW,Fismen S,Gutteberg T,et al.Triage of women with minor cervical lesions:data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing[J].PLoS One,2010,5:e12724.
  • 6Stanley J,Roobboy Malcolm C,anderson Peter Russell.女性生殖道病理学[M].回允中,译.北京:北京大学医学出版社,2005.153~161.
  • 7刘桐宇,谢榕,Lulu Zhang,郑雄伟,陈刚,何诚,林玉珍,杨琳,李桑.TCT标本检测高危HPV E6/E7mRNA及在宫颈病变中的应用研究[J].中华妇幼临床医学杂志(电子版),2011,7(3):166-169. 被引量:35
  • 8Beglin M,Melar-New M,Laimins L.Human papillomaviruses and the interferon response[J].J Interferon Cytokine Res,2009,29:629-635.
  • 9Burger EA,Kornon H,Klemp M,et al.HPV mRNA tests for the detection of cervical intraepithelial neoplasia:a systematic review[J].Gynecol Oncol,2011,120:430-438.
  • 10Cattani P,Zannoni GF,Ricci C,et al.Clinical performance of humanpapillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix[J].J Clin Microbiol,2009,47:3895-3901.

二级参考文献31

  • 1刘彬,陈汶,任生达,刘新伏,马俊飞,崔剑峰,王秀荣,陈凤,乔友林.液基细胞学剩余标本筛查子宫颈病变中人乳头状瘤病毒DNA的应用[J].中华检验医学杂志,2005,28(5):495-497. 被引量:18
  • 2Mu(n)oz N,Castellsagué X,de González AB,et al.Chapter 1:HPV in the etiology of human cancer[J].Vaccine,2006,24(Suppl 3):S3/1-10.
  • 3Brink AA,Snijders PJ,Meijer CJ,et al.HPV testing in cervical screening[J].Best Praet Res Clin Obstet Gynaecol,2006,20(2):253-266.
  • 4Lie AK,Kristensen G.Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical cancinoma[J].Expert Rev Mol Diagn,2008,8(4):405-415.
  • 5Castle PE,Dockter J,Giachetti C,et al.A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical preeancer and cancer[J].Clin Cancer Res,2007,13(9):2599-2605.
  • 6Andersson S,Hansson B,Norman I,et al.Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade,viral load and p161NK4a[J].Int J Oncol,2006,29(3):705-711.
  • 7Molden T,Nygard JF,Kraus I,et al.Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR:A 2-year follow-up of women with ASCUS or LSIL Pap smear[J].Int J Cancer,2005,114(6):973-976.
  • 8Saeterdal IM,Juvet LK,Norderhaug IN.HPV RNA test for cervical cancer[R].Rapport fra Kunnskapssenteret,NOKC nr 02-2008.
  • 9Cuschieri K,Wentzensen N.Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia[J].Cancer Epidemiol Biomarkers Prey,2008,17(10):2536-2545.
  • 10Bianchi A,Moret F,Desrues JM,et al.PreservCyt transport medium used for the ThinPrep Pap test is a suitable medium for detection of Chlamydia trachomatis by the COBAS Amplicor CT/NG test:Results of a preliminary study and future implications[J].J Clin Microbiol,2002,40(5):1749-1754.

共引文献73

同被引文献17

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部